Jump to content
IndiaDivine.org

[alternacare] JAMA AND MERCK

Rate this topic


Guest guest

Recommended Posts

Guest guest

When is news that is passed on to TV stations

and newspapers by " off

 

 

Posted by: " Rich Putman "

rich.putman

richputman

 

 

 

Wed Apr 30, 2008 12:35 pm (PDT)

The short article below cites an unethical practice by the

pharmaceutical

firm Merck. This time, Merck was caught. But the article indicates

*the

unethical behavior is common in the prescription drug industry.*

Sources are

cited at the end of the article. Note: I sent almost the same email

to news

media in my area. It's so common that they pass on drug-related news

as

reliable. Would you like to send the letter to news media news

directors in

your area?

= = = = = = = = = = =

Earlier this month, the Journal of the American Medical Association

(JAMA)

spilled the beans.

With two articles and an editorial, researchers offered precise

details

about Merck's very aggressive Vioxx sales strategy, which included a

practice that's not well known among the general public:

ghostwriting.

Many of the drug studies and reviews that appear in the most

prestigious

medical journals are actually written by drug company employees or

ghostwriters in medical publishing firms. The drug companies then

pay

prominent academics in return for simply placing their names among

the

authors. In some cases, the academics really do review the studies,

make

changes, and then add their names to the author list.

The researchers of the JAMA articles found clear evidence of this

practice

when they examined court documents related to the thousands of

lawsuits

brought against Merck after Vioxx was pulled from the market in 2004

because

of increased risk of heart attack and stroke. This past November,

Merck paid

close to $5 billion to settle those lawsuits out of court.

Yes, you read that correctly – that's five billion, with a B. That's

the

kind of money a giant drug company can spare to make an inconvenient

problem

go away.

-----------

Crime wave

-----------

Beyond the fact that Merck used ghostwriters for clinical studies

and

reviews of Vioxx that appeared in several prominent medical journals,

a MUCH

more disturbing trend is revealed by the JAMA articles: further

evidence

that safety information was withheld.

In the second of the two articles, the authors write, " In April

2001, the

company's internal intention-to-treat analyses of pooled data from

these 2

trials identified a significant increase in total mortality. These

mortality

analyses were neither provided to the FDA nor made public in a

timely

fashion. " The authors also noted that in a 2001 Safety Update

Report for the

FDA, Merck " minimized the appearance of any mortality

risk. "

The JAMA editorial calls the two articles " a glimpse of one

company's

apparent misrepresentation of research data and its manipulation of

clinical

research articles and clinical reviews. "

Steven Nissen of the Cleveland Clinic is quite a bit more direct. He

described the revelations to HealthDay News as " a very ugly

picture of

medicine really at its worst. " And he summed up the true

scandal: " The thing

that you can't lose in all of this, amid the corporate misconduct

story, is

that patients were harmed. "

But let's be even more direct: They weren't harmed, they were killed.

And

let's call Merck's actions what they really are: criminal.

= = = = = =

* Sources for the above article:*

" Guest Authorship and Ghostwriting in Publications Related to

Rofecoxib "

Journal of the American Medical Association, Vol. 299, No. 15,

4/16/08,

jama.ama-assn.org

" Reporting Mortality Findings in Trials of Rofecoxib for

Alzheimer Disease

or Cognitive Impairment " Journal of the American Medical

Association, Vol.

299, No. 15, 4/16/08, jama.ama-assn.org

" Impugning the Integrity of Medical Science " Journal of the

American Medical

Association, Vol. 299, No. 15, 4/16/08, jama.ama-assn.org

" Key Vioxx Research Was Written by Merck, Documents Allege "

Amanda Gardner,

HealthDay News, 4/15/08, washingtonpost.com

" The Water Shortage and How to Fix It " William Campbell

Douglass III, M.D.,

Daily Dose, 1/21/08, douglassreport.com

****************************************************

The article appeared in the 4/30/2008 edition of the HSI e-Alert

free

newsletter

by

www.hsibaltimore.com,

L.L.C. - the Health Sciences Institute of

Baltimore.

= = = = = =

At 06:29 AM 5/1/08, you wrote:

When is news that is passed on to

TV stations and newspapers by " off

Posted by: " Rich Putman " rich.putman

richputman

Wed Apr 30, 2008 12:35 pm (PDT)

The short article below cites an unethical practice by the

pharmaceutical

firm Merck. This time, Merck was caught. But the article indicates

*the

unethical behavior is common in the prescription drug industry.* Sources

are

cited at the end of the article. Note: I sent almost the same email to

news

media in my area. It's so common that they pass on drug-related news

as

reliable. Would you like to send the letter to news media news directors

in

your area?

= = = = = = = = = = =

Earlier this month, the Journal of the American Medical Association

(JAMA)

spilled the beans.

With two articles and an editorial, researchers offered precise

details

about Merck's very aggressive Vioxx sales strategy, which included a

practice that's not well known among the general public:

ghostwriting.

Many of the drug studies and reviews that appear in the most

prestigious

medical journals are actually written by drug company employees or

ghostwriters in medical publishing firms. The drug companies then

pay

prominent academics in return for simply placing their names among

the

authors. In some cases, the academics really do review the studies,

make

changes, and then add their names to the author list.

The researchers of the JAMA articles found clear evidence of this

practice

when they examined court documents related to the thousands of

lawsuits

brought against Merck after Vioxx was pulled from the market in 2004

because

of increased risk of heart attack and stroke. This past November, Merck

paid

close to $5 billion to settle those lawsuits out of court.

Yes, you read that correctly ­ that's five billion, with a B. That's

the

kind of money a giant drug company can spare to make an inconvenient

problem

go away.

-----------

Crime wave

-----------

Beyond the fact that Merck used ghostwriters for clinical studies

and

reviews of Vioxx that appeared in several prominent medical journals, a

MUCH

more disturbing trend is revealed by the JAMA articles: further

evidence

that safety information was withheld.

In the second of the two articles, the authors write, " In April

2001, the

company's internal intention-to-treat analyses of pooled data from these

2

trials identified a significant increase in total mortality. These

mortality

analyses were neither provided to the FDA nor made public in a

timely

fashion. " The authors also noted that in a 2001 Safety Update Report

for the

FDA, Merck " minimized the appearance of any mortality

risk. "

The JAMA editorial calls the two articles " a glimpse of one

company's

apparent misrepresentation of research data and its manipulation of

clinical

research articles and clinical reviews. "

Steven Nissen of the Cleveland Clinic is quite a bit more direct. He

described the revelations to HealthDay News as " a very ugly picture

of

medicine really at its worst. " And he summed up the true scandal:

" The thing

that you can't lose in all of this, amid the corporate misconduct story,

is

that patients were harmed. "

But let's be even more direct: They weren't harmed, they were killed.

And

let's call Merck's actions what they really are: criminal.

= = = = = =

* Sources for the above article:*

" Guest Authorship and Ghostwriting in Publications Related to

Rofecoxib "

Journal of the American Medical Association, Vol. 299, No. 15,

4/16/08,

jama.ama-assn.org

" Reporting Mortality Findings in Trials of Rofecoxib for Alzheimer

Disease

or Cognitive Impairment " Journal of the American Medical

Association, Vol.

299, No. 15, 4/16/08, jama.ama-assn.org

" Impugning the Integrity of Medical Science " Journal of the

American Medical

Association, Vol. 299, No. 15, 4/16/08, jama.ama-assn.org

" Key Vioxx Research Was Written by Merck, Documents Allege "

Amanda Gardner,

HealthDay News, 4/15/08, washingtonpost.com

" The Water Shortage and How to Fix It " William Campbell

Douglass III, M.D.,

Daily Dose, 1/21/08, douglassreport.com

****************************************************

The article appeared in the 4/30/2008 edition of the HSI e-Alert

free

newsletter

by

www.hsibaltimore.com,

L.L.C. - the Health Sciences Institute of

Baltimore.

= = = = = =

 

******

Kraig and Shirley Carroll ... in the woods of SE Kentucky

http://www.thehavens.com/

thehavens

606-376-3363

 

 

 

---

Outgoing mail is certified Virus Free.

Checked by AVG anti-virus system (http://www.grisoft.com).

Version: 6.0.859 / Virus Database: 585 - Release 2/14/05

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...